Drug intelligence / Profile preview

Age Gard TX

Development stage: Unknown
Lead developer: VTS Life Sciences
Modality: Peptides, Small Molecules
Administration: Oral

Overview

**Age Gard TX** is a VTS Life Sciences-marketed oral fixed-dose tablet formulation listed in the company’s product catalogue. A product listing identifies the active ingredients as tranexamic acid and glutathione. Tranexamic acid is an antifibrinolytic lysine analogue that reversibly occupies lysine-binding sites on plasminogen, limiting plasmin generation; its dermatologic use for pigmentary disorders is distinct from its hemostatic pharmacology. The exact dose strengths, regulatory status, manufacturing site, and indication for the non-Forte Age Gard TX product were not stated in the primary company catalogue. ([vtslifesciences.in](https://vtslifesciences.in/products.html))

Brand names: Age Gard TX

Targets

TYR (Tyrosinase)PLG (Plasminogen)

Beyond the preview

Go deeper on Age Gard TX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Age Gard TX.

Explore the full profile